Docetaxel Micelles: A New Formulation to Diminish Hypersensitivity Reactions
Background/Objectives: Docetaxel is a potent anti-cancer agent capable of treating various types of cancer.However, it often induces a range of adverse reactions when used with its standard solubilizer, Tween-80, necessitating allergy prophylaxis with dexamethasone prior to administration.To mitigate the risk of allergic reactions, with nanomicelle